XL-MAB
LIVE

Serial Number

99779946

Owner

XL-protein GmbH

Attorney

Anthony Craig

Filing Date

Apr 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

XL-MAB Trademark

Serial Number: 99779946

XL-MAB is a trademark filed by XL-protein GmbH on April 22, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

XL-protein GmbH (5 trademarks)

Lise-Meitner-Str. 30
Freising 85354 , DE

Entity Type: 03

Trademark Details

Filing Date

April 22, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders, ophthalmological diseases, infectious diseases, obesity, diabetes, bone diseases, diseases of the central nervous system, and diseases which can be treated or ameliorated by binding to, or activation or blocking of, a target antigen; proteins, recombinant binding proteins and conjugates of recombinant binding proteins including protein-drug conjugates; pharmaceutical and veterinary preparations comprising proteins, recombinant binding proteins and conjugates of recombinant binding proteins

Scientific services and research relating thereto in the fields of biology, chemistry or medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, proteins, and/or medical and veterinary preparations, diagnostic preparations and biomarker reagents and/or diagnostic apparatus

Chemical, biochemical, biological, and biotechnological preparations, in particular, proteins, recombinant binding proteins and conjugates of recombinant binding proteins for industrial and scientific use; proteins, in particular recombinant binding proteins and conjugates of recombinant binding proteins for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, proteins, in particular recombinant binding proteins and conjugates of recombinant binding proteins for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION ENTERED
Apr 22, 2026 NWAP